Literature DB >> 16575491

Rare association of antiphospholipid syndrome and Takayasu arteritis.

Mittermayer B Santiago1, Otávio Paz.   

Abstract

The antiphospholipid syndrome (APS) is characterized by obstetric and thrombotic complications in the presence of antiphospholipid antibodies. It can happen in an isolated way or in association with diffuse connective tissue diseases, mainly systemic lupus erythematosus. The association of APS with Takayasu arteritis (TA) is rarely described in the literature. We described a case of primary APS in a female patient who developed obstruction in large-size arteries, in spite of the use of oral anticoagulant, and increase of erythrocyte sedimentation rate, suggesting TA. The favorable response to prednisone treatment and later to infliximab reinforced the diagnosis of TA. The present report illustrates the existence of APS associated to TA, whose recognition is very important once the therapeutic strategy is radically different.

Entities:  

Mesh:

Year:  2006        PMID: 16575491     DOI: 10.1007/s10067-006-0277-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

Review 1.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Authors:  W A Wilson; A E Gharavi; T Koike; M D Lockshin; D W Branch; J C Piette; R Brey; R Derksen; E N Harris; G R Hughes; D A Triplett; M A Khamashta
Journal:  Arthritis Rheum       Date:  1999-07

2.  Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

Authors:  A Della Rossa; A Tavoni; G Merlini; C Baldini; M Sebastiani; M Lombardi; D Neglia; S Bombardieri
Journal:  Rheumatology (Oxford)       Date:  2005-04-19       Impact factor: 7.580

3.  Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome.

Authors:  V Caso; M Paciaroni; L Parnetti; G Cardaioli; L Biscarini; A E Acciarini; S Rubino; V Gallai
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

4.  Absence of antiphospholipid/co-factor antibodies in Takayasu arteritis.

Authors:  A Nava; J L Senécal; J L Bañales; I Raymond; P A Reyes
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

5.  Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.

Authors:  Gary S Hoffman; Peter A Merkel; Richard D Brasington; Deborah J Lenschow; Patrick Liang
Journal:  Arthritis Rheum       Date:  2004-07

6.  Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases.

Authors:  K Yokoi; E Hosoi; M Akaike; T Shigekiyo; S Saito
Journal:  Angiology       Date:  1996-03       Impact factor: 3.619

  6 in total
  3 in total

1.  Novel strategy for the treatment of refractory vasculitis syndrome.

Authors:  Hidehiro Yamada
Journal:  Ann Vasc Dis       Date:  2013-02-15

2.  Takayasu arteritis and antiphospholipid antibody syndrome in an elderly woman.

Authors:  Hee-Jeong Lee; Jae Pil Hwang; Hyun-Sook Kim
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

3.  Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review.

Authors:  Shoichi Fukui; Shogo Hirota; Naoki Iwamoto; Hiroki Karata; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.